Aktuellt
SENASTE
Redeye is intrigued by the publication released yesterday indicating an antidepressant-like activity with ACD856 in several pre-clinical models. We think that the drug candidate has several interesting characteristics, including potentially a disease modifying effect, that will position it well if replicated in the clinic. We will discuss the recent publications further in relation to our Q2 update.
LÄS MER
